{"id":51701,"date":"2025-08-21T10:35:58","date_gmt":"2025-08-21T10:35:58","guid":{"rendered":"https:\/\/dailyhomeland.com\/?p=51701"},"modified":"2025-08-21T10:35:58","modified_gmt":"2025-08-21T10:35:58","slug":"from-ldc-to-middle-income-country-the-future-of-bangladeshs-pharmaceutical-industry-dr-m-n-alam","status":"publish","type":"post","link":"https:\/\/dailyhomeland.com\/?p=51701","title":{"rendered":"&#8220;From LDC to Middle-Income Country: The Future of Bangladesh&#8217;s Pharmaceutical Industry&#8221; \u2013 Dr. M. N. Alam"},"content":{"rendered":"<p>Recently, entrepreneurs from various export-oriented sectors, including pharmaceuticals, garments, leather, and software, have expressed concerns that different industries could face risks in the post-TRIPS era. Under the TRIPS Agreement, the production and marketing of products in the international arena are subject to various intellectual property rules, including copyright, patent, trademark, and GI protections. According to TRIPS, if a company discovers a new drug and markets it, the drug becomes patent-protected. The company or institution holding the patent is granted exclusive rights to operate in the country for 20 years. Before the completion of these twenty years, no other pharmaceutical company can manufacture or market the patented drug. After this period, any company has the right to produce and market the drug under a generic name. The production and marketing of the drug as a generic considerably reduce its price. Consequently, companies in other countries can produce and market it at a lower cost, allowing the general public to purchase medicines affordably and save lives.<\/p>\n<p>When the TRIPS Agreement came into force in 1995, the Doha Declaration granted fifty-five least developed countries (LDCs) the opportunity to produce and market medicines without patent restrictions until 2016, which was later extended to 2033.<\/p>\n<p>On 24 November 2026, Bangladesh will formally graduate from LDC status to a middle-income country. As a result, Bangladeshi pharmaceutical companies may lose the existing opportunity to manufacture and market generic versions of foreign patented medicines under the TRIPS waiver. This could lead to higher medicine prices and make it difficult for the country\u2019s pharmaceutical exports to remain competitive. To mitigate post-TRIPS risks, pharmaceutical companies have applied to the Directorate General of Drug Administration for approval from the Drug Control Committee (DCC) to register nearly 1,000 new drugs.<\/p>\n<p>Due to political changes on 5 August 2024, DCC meetings were not held for some time. On 4 August 2025, the government reconstituted the 22-member Drug Control Committee, with the Secretary of the Ministry of Health and Family Welfare as Chairperson and the Director General of the Directorate General of Drug Administration as Member Secretary. According to the committee\u2019s mandate, the DCC evaluates the safety, efficacy, and usability of medicines and recommends approval or cancellation of registration to the licensing authority. All members must declare, in a prescribed form, that they have no conflict of interest with any relevant institution or individual at the time of assuming responsibilities.<\/p>\n<p>Currently, Bangladesh has 310 allopathic drug manufacturing companies, of which only the Essential Drugs Company Ltd. (EDCL) is public; the rest are privately owned. The contribution of private entrepreneurs to the pharmaceutical industry is widely recognized. It is undeniable that privately-owned pharmaceutical companies took risks to invest here, transforming the largely import-dependent medicine sector into a promising export-oriented industry after independence. Meeting 98% of domestic demand, Bangladesh exports medicines to 160 countries worldwide. Approximately 200,000 highly educated professionals, including chemists, pharmacists, and microbiologists, are employed in this sector. The absence of pharmaceutical industry representatives in the DCC has drawn criticism. However, based on the country\u2019s experience, it can be observed that if influential MPs or government ministers with ownership in pharmaceutical companies participate in DCC or pricing committee meetings, conflicts of interest may arise, potentially affecting public health. Accordingly, the World Health Organization\u2019s 2022 guidelines recommend avoiding conflicts of interest in LDCs. Even without representatives, pharmaceutical companies can appeal decisions against their interests under the Drugs and Cosmetics Act 2023.<\/p>\n<p>Until now, companies have utilized patent exemptions to produce generic versions of medicines. However, in the near future, competing in global markets will not be possible without support from multinational giants. Therefore, pharmaceutical companies must focus on research and development, including process development, clinical trials, and innovation of generic and biological medicines, instead of merely importing raw materials. Investment in skilled personnel, advanced technology, and infrastructure is essential to develop new drugs.<\/p>\n<p>Although domestic companies have acquired the capacity to produce essential medicines, progress in research and development remains limited. Delaying LDC graduation by six years, as some quarters have suggested, will not realistically allow them to achieve substantial advancements in this field. To address TRIPS-related challenges, in 2007, the government allocated 42 Active Pharmaceutical Ingredient (API) plants to 27 companies in Gozaria, Munshiganj. Despite 22 years having passed, only four companies have started API production. The government must ensure immediate commencement of API production by the remaining companies and provide necessary support.<\/p>\n<p>Just as the pharmaceutical sector achieved unprecedented growth after 1982 by overcoming domestic and foreign challenges, it is our firm belief that, by jointly addressing post-TRIPS challenges through government-private sector collaboration and R&#038;D\u2014including API production and innovation of new generic-biological medicines\u2014the pharmaceutical industry in Bangladesh will continue to advance.<\/p>\n<p><strong>Author: Former Deputy Director &#038; Legal Officer<br \/>\nDirectorate General of Drug Administration, Dhaka<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recently, entrepreneurs from various export-oriented sectors, including pharmaceuticals, garments, leather, and software, have expressed concerns that different industries could face risks in the post-TRIPS era. Under the TRIPS Agreement, the production and marketing of products in the international arena are subject to various intellectual property rules, including copyright, patent, trademark, and GI protections. According to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":51702,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","jetpack_publicize_message":"&nbsp;","jetpack_is_tweetstorm":false},"categories":[50,48,39],"tags":[],"jetpack_featured_media_url":"https:\/\/dailyhomeland.com\/wp-content\/uploads\/2025\/08\/alam.png","jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/51701"}],"collection":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=51701"}],"version-history":[{"count":1,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/51701\/revisions"}],"predecessor-version":[{"id":51703,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/51701\/revisions\/51703"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/media\/51702"}],"wp:attachment":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=51701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=51701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=51701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}